Who owns GYRE THERAPEUTICS INCORPORATED?
- Ticker: GYRE
- CUSIP Number: 403783103
Tip: Access positions for across all investors
Analyze quarterly positions in Gyre Therapeutics Incorporated with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gyre Therapeutics Incorporated stock
Who bought or sold GYRE THERAPEUTICS INCORPORATED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 532k | $6.4M | 3% | Dec 2024 |
|
| Vanguard Group | 323k | $3.9M | -5% | Dec 2024 |
|
| Geode Capital Management | 304k | $3.7M | 0% | Dec 2024 |
|
| State Street Corporation | 127k | $1.5M | 21% | Dec 2024 |
|
| Charles Schwab Investment Management | 115k | $1.4M | 1% | Dec 2024 |
|
| Northern Trust | 103k | $1.3M | 9% | Dec 2024 |
|
| SBI Securities | 101k | $1.2M | 100% | Dec 2024 |
|
| UBS Group | 57k | $691k | 1467% | Dec 2024 |
|
| Goldman Sachs Group | 26k | $319k | 40% | Dec 2024 |
|
| Belvedere Trading | 23k | $272k | 0% | Dec 2024 |
|
| Morgan Stanley | 15k | $184k | -16% | Dec 2024 |
|
| Bank of New York Mellon | 14k | $168k | 11% | Dec 2024 |
|
| Barclays | 11k | $128k | 14% | Dec 2024 |
|
| Rhumbline Advisers | 10k | $126k | 0% | Dec 2024 |
|
| Advantage Alpha Capital Partners | 8.9k | $107k | -67% | Dec 2024 |
|
| Bank of America Corporation | 6.9k | $84k | 40% | Dec 2024 |
|
| Citigroup | 5.4k | $65k | 6% | Dec 2024 |
|
| Wells Fargo & Company | 4.0k | $49k | 29% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 3.9k | $48k | 100% | Sep 2024 |
|
| Corebridge Financial | 3.5k | $42k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 3.3k | $40k | 8% | Dec 2024 |
|
| New York State Common Retirement Fund | 2.7k | $33k | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $17k | -28% | Dec 2024 |
|
| FMR | 1.3k | $15k | -66% | Dec 2024 |
|
| Picton Mahoney Asset Management | 1.1k | $14k | 100% | Dec 2024 |
|
| Tower Research Capital | 852.00 | $10k | -1% | Dec 2024 |
|
| Royal Bank of Canada | 810.00 | $10k | -16% | Dec 2024 |
|
| Summit Investment Advisors | 683.00 | $8.3k | 0% | Dec 2024 |
|
| Legal & General Group | 603.00 | $7.3k | 0% | Dec 2024 |
|
| Activest Wealth Management | 533.00 | $6.4k | 0% | Dec 2024 |
|
| California State Teachers Retirement System | 505.00 | $6.1k | 0% | Dec 2024 |
|
| Advisor Group Holdings | 427.00 | $5.4k | -3% | Dec 2024 |
|
| Amalgamated Bank | 241.00 | $3.0k | 0% | Dec 2024 |
|
| Sterling Capital Management | 216.00 | $2.6k | 929% | Dec 2024 |
|
| NISA Investment Advisors | 84.00 | $1.0k | 0% | Dec 2024 |
|
| CWM | 15.00 | $0 | -50% | Dec 2024 |
|
| GAMMA Investing | 12.00 | $144.999600 | 100% | Dec 2024 |
|
| Covestor | 6.00 | $0 | 100% | Sep 2024 |
|
| IFP Advisors | 2.00 | $24.000000 | 100% | Dec 2024 |
|
Who sold out of Gyre Therapeutics Incorporated?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Capital Performance Advisors | Sep 2024 | 6.00 | $75.000000 |